NCT01018043

Thai Cancer Anemia Survey in Chulalongkorn Hospital

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 264 (actual)
• Sponsor: Janssen-Cilag Ltd.,Thailand · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to create a large Thailand database documenting the severity of anemia and its management in the cancer population.

Detailed description

Thai Cancer Anemia Study (TCAS) is a prospective survey that will track anemia management in an adult cancer population. This survey is not intended to interfere with standard medical practices for handling anemia. Information on laboratory values including target and achieved hemoglobin (Hb) levels during chemotherapy cycles, use of blood transfusions, iron supplementation, and epoetin will be collected in addition to information on cancer status and treatment. Data on the level that triggers clinicians to decide on the need for anemia therapy will also be collected. Each patient included in the survey will be followed for six months. Observational Study - No investigational drug administered

Conditions

• Anemia
• Cancer

Interventions

Type	Name	Description
OTHER	Adult Cancer Patients	Tracking anemia management in Adult Cancer Patients

Timeline

• Start date: 2006-04-01
• Primary completion: 2009-12-01
• Completion: 2009-12-01
• First posted: 2009-11-23
• Last updated: 2014-05-23

Locations

1 site across 1 country: Thailand